Herb Greenberg makes the case for GoodRx

Herb Greenberg, senior editor, Empire Financial Research and CNBC contributor, joins FM to make his pitch for GoodRx stock. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Dan Nathan and Karen Finerman.